Aura Biosciences (AURA) Other financing activities (2020 - 2026)

Aura Biosciences (AURA) has 7 years of Other financing activities data on file, last reported at $123000.0 in Q1 2026.

• Quarterly Other financing activities changed N/A year-over-year to $123000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.1 million (down 10.08% YoY) and the FY2025 annual result came in at $1.0 million, down 28.77% from the prior year.
• Other financing activities rose to $123000.0 in Q1 2026, from -$13.1 million in the prior quarter.
• In the past five years, Other financing activities ranged from a high of $14.2 million in Q2 2025 to a low of -$13.1 million in Q3 2025.
• A 5-year average of $239153.8 and a median of $123000.0 in 2026 frame the typical range for Other financing activities.
• The widest YoY moves for Other financing activities: up 22569.84% in 2025, down 1785.38% in 2025.
• Tracing AURA's Other financing activities over 5 years: stood at $104000.0 in 2022, then tumbled by 30.77% to $72000.0 in 2023, then jumped by 654.17% to $543000.0 in 2024, then slumped by 2520.99% to -$13.1 million in 2025, then jumped by 100.94% to $123000.0 in 2026.
• The last three Other financing activities figures came in at $123000.0 (Q1 2026), -$13.1 million (Q3 2025), and $14.2 million (Q2 2025), per Business Quant data.